Certain patients from Minnesota have reported "significant" benefits from using medical marijuana in aiding their sickness. This conclusion was derived from the recent survey conducted by the state from July 2015 to June 2016.
In an article published by Duluth News Tribune, the majority of patients said that medicinal marijuana drew benefits for them after they switched from other medications. Using the rating scale from one, as the equivalence to no benefit, to 7, as the equivalence of great benefit, 64 percent of respondents gave a 6 or 7 when asked about how they think medical cannabis have helped them.
In the same survey, only 9 percent of the respondents gave a low score of 1, 2, or 3 about the benefits of medicinal marijuana. "Based on this evidence from the first year, Minnesota's approach is providing many people with substantial benefits, minimal side effects and no serious adverse events," Health Commissioner Dr. Ed Ehlinger said.
In an article published in Twin Cities, there is less than 25 percent of patient respondents who said that they received the negative side effects from using medicinal marijuana for their illnesses. So far, no patients using medicinal marijuana in Minnesota have been reported to have severe negative side effects that require being confined in hospitals.
LeafLine Labs CEO and Co-Founder Dr. Andrew Bachman said that he was not surprised by the "extremely positive results" of the medicinal marijuana survey. "We have the privilege of seeing patients every day that [has] benefited from our life-changing medicine and care, whether through symptomatic treatment, cure, or just a better quality of life in general," he said.
LeadLine Labs is one of the two leading medical marijuana producers in the state. Bachman added that LeafLine Labs is committed to our medicine and care to be first & ultimately accessible as only 22 months after first opening our Care Center doors, our average monthly cost is already less than $200 per month, and they are excited to continue that trend as the program continues to grow.
